US Stock MarketDetailed Quotes

Assembly Biosciences (ASMB)

Watchlist
  • 27.875
  • +0.255+0.92%
Trading Jan 23 13:28 ET
440.90MMarket Cap-6.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Assembly Biosciences (ASMB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
57.62%10.79M
12.81%9.63M
62.82%9.42M
298.16%28.52M
2.71%7.36M
6.85M
8.53M
5.79M
7.16M
7.16M
Operating revenue
57.62%10.79M
12.81%9.63M
62.82%9.42M
298.16%28.52M
2.71%7.36M
--6.85M
--8.53M
--5.79M
--7.16M
--7.16M
Cost of revenue
Gross profit
Operating expense
21.75%21.67M
-0.08%20.72M
17.23%19.36M
2.97%73.94M
-4.18%18.89M
18.29%17.8M
18.57%20.74M
-15.57%16.51M
-23.70%71.81M
-14.20%19.71M
Selling and administrative expenses
18.64%5.09M
2.61%4.59M
-2.72%4.51M
-21.40%18.01M
-47.07%4.61M
1.47%4.29M
-9.83%4.48M
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
-General and administrative expense
18.64%5.09M
2.61%4.59M
-2.72%4.51M
-21.40%18.01M
-47.07%4.61M
1.47%4.29M
-9.83%4.48M
-7.52%4.64M
-5.08%22.91M
42.17%8.71M
Research and development costs
22.73%16.59M
-0.82%16.13M
25.02%14.85M
14.38%55.93M
29.75%14.28M
24.86%13.52M
29.83%16.26M
-18.34%11.88M
-30.12%48.9M
-34.69%11.01M
Operating profit
0.67%-10.88M
9.10%-11.09M
7.34%-9.94M
29.74%-45.42M
8.12%-11.53M
27.19%-10.96M
30.22%-12.2M
45.15%-10.73M
31.31%-64.65M
45.38%-12.55M
Net non-operating interest income expense
25.61%1.69M
-38.57%895K
-32.02%1.12M
61.49%5.57M
-30.89%1.12M
113.85%1.34M
146.11%1.46M
171.26%1.65M
237.67%3.45M
178.22%1.62M
Non-operating interest income
25.61%1.69M
-38.57%895K
-32.02%1.12M
61.49%5.57M
-30.89%1.12M
113.85%1.34M
146.11%1.46M
171.26%1.65M
237.67%3.45M
178.22%1.62M
Other net income (expense)
Income before tax
4.34%-9.2M
5.10%-10.2M
2.85%-8.82M
34.89%-39.85M
4.74%-10.41M
33.34%-9.61M
36.40%-10.75M
52.10%-9.08M
34.26%-61.2M
51.20%-10.93M
Income tax
0
0
900.00%330K
-330.30%-76K
0
406K
33K
33K
Net income
4.34%-9.2M
8.55%-10.2M
2.85%-8.82M
34.38%-40.18M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
Net income continuous Operations
4.34%-9.2M
8.55%-10.2M
2.85%-8.82M
34.38%-40.18M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
Minority interest income
Net income attributable to the parent company
4.34%-9.2M
8.55%-10.2M
2.85%-8.82M
34.38%-40.18M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.34%-9.2M
8.55%-10.2M
2.85%-8.82M
34.38%-40.18M
5.72%-10.34M
33.34%-9.61M
34.00%-11.15M
52.10%-9.08M
34.23%-61.23M
51.05%-10.96M
Basic earnings per share
52.32%-0.72
32.83%-1.33
29.52%-1.17
50.00%-6.69
11.30%-1.57
54.10%-1.51
48.97%-1.98
62.78%-1.66
42.03%-13.38
68.17%-1.77
Diluted earnings per share
52.32%-0.72
32.83%-1.33
29.52%-1.17
50.00%-6.69
11.30%-1.57
54.10%-1.51
48.97%-1.98
62.78%-1.66
42.03%-13.38
68.17%-1.77
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 57.62%10.79M12.81%9.63M62.82%9.42M298.16%28.52M2.71%7.36M6.85M8.53M5.79M7.16M7.16M
Operating revenue 57.62%10.79M12.81%9.63M62.82%9.42M298.16%28.52M2.71%7.36M--6.85M--8.53M--5.79M--7.16M--7.16M
Cost of revenue
Gross profit
Operating expense 21.75%21.67M-0.08%20.72M17.23%19.36M2.97%73.94M-4.18%18.89M18.29%17.8M18.57%20.74M-15.57%16.51M-23.70%71.81M-14.20%19.71M
Selling and administrative expenses 18.64%5.09M2.61%4.59M-2.72%4.51M-21.40%18.01M-47.07%4.61M1.47%4.29M-9.83%4.48M-7.52%4.64M-5.08%22.91M42.17%8.71M
-General and administrative expense 18.64%5.09M2.61%4.59M-2.72%4.51M-21.40%18.01M-47.07%4.61M1.47%4.29M-9.83%4.48M-7.52%4.64M-5.08%22.91M42.17%8.71M
Research and development costs 22.73%16.59M-0.82%16.13M25.02%14.85M14.38%55.93M29.75%14.28M24.86%13.52M29.83%16.26M-18.34%11.88M-30.12%48.9M-34.69%11.01M
Operating profit 0.67%-10.88M9.10%-11.09M7.34%-9.94M29.74%-45.42M8.12%-11.53M27.19%-10.96M30.22%-12.2M45.15%-10.73M31.31%-64.65M45.38%-12.55M
Net non-operating interest income expense 25.61%1.69M-38.57%895K-32.02%1.12M61.49%5.57M-30.89%1.12M113.85%1.34M146.11%1.46M171.26%1.65M237.67%3.45M178.22%1.62M
Non-operating interest income 25.61%1.69M-38.57%895K-32.02%1.12M61.49%5.57M-30.89%1.12M113.85%1.34M146.11%1.46M171.26%1.65M237.67%3.45M178.22%1.62M
Other net income (expense)
Income before tax 4.34%-9.2M5.10%-10.2M2.85%-8.82M34.89%-39.85M4.74%-10.41M33.34%-9.61M36.40%-10.75M52.10%-9.08M34.26%-61.2M51.20%-10.93M
Income tax 00900.00%330K-330.30%-76K0406K33K33K
Net income 4.34%-9.2M8.55%-10.2M2.85%-8.82M34.38%-40.18M5.72%-10.34M33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M
Net income continuous Operations 4.34%-9.2M8.55%-10.2M2.85%-8.82M34.38%-40.18M5.72%-10.34M33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M
Minority interest income
Net income attributable to the parent company 4.34%-9.2M8.55%-10.2M2.85%-8.82M34.38%-40.18M5.72%-10.34M33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.34%-9.2M8.55%-10.2M2.85%-8.82M34.38%-40.18M5.72%-10.34M33.34%-9.61M34.00%-11.15M52.10%-9.08M34.23%-61.23M51.05%-10.96M
Basic earnings per share 52.32%-0.7232.83%-1.3329.52%-1.1750.00%-6.6911.30%-1.5754.10%-1.5148.97%-1.9862.78%-1.6642.03%-13.3868.17%-1.77
Diluted earnings per share 52.32%-0.7232.83%-1.3329.52%-1.1750.00%-6.6911.30%-1.5754.10%-1.5148.97%-1.9862.78%-1.6642.03%-13.3868.17%-1.77
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.41%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.96%
4
Amazon
AMZN
+2.21%
5
NVIDIA
NVDA
+1.62%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.44%
Sample Name
Sample Code
 +8.88%
Sample Name
Sample Code
 +4.39%
4
Pony AI
PONY
+4.25%
5
H World Group
HTHT
+4.16%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -